Programs, populations, and payments verified via SAMHSA.
- Level of care
- Detox · Inpatient · PHP · IOP · MAT · Dual Dx · Telehealth
- Service settings
- Outpatient, Residential/24-hour residential, Outpatient detoxification, Outpatient day treatment or partial hospitalization, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment, Residential detoxification, Short-term residential
- Therapy approaches
- Anger management, Brief intervention, Cognitive behavioral therapy, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Trauma-related counseling, Telemedicine/telehealth therapy
- Age groups
- Children/Adolescents
- Special populations
- Adult women, Pregnant/postpartum women, Adult men, Clients with co-occurring mental and substance use disorders, Clients who have experienced trauma
- Medications used
- Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine without naloxone, Naltrexone (oral), Naltrexone (extended-release, injectable), Clonidine, Medication for mental disorders, Medications for pre-exposure to prophylaxis, Nicotine replacement, Non-nicotine smoking/tobacco cessation
- Recovery supports
- Housing services, Assistance with obtaining social services, Recovery coach, Mentoring/peer support, Employment counseling or training
- Facility operation
- State government